FMRP RNA targets: identification and validation

被引:86
作者
Darnell, JC
Mostovetsky, O
Darnell, RB
机构
[1] Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
关键词
FMRP; Fragile X Syndrome; KH domain; nova; polyribosome; RNA-binding protein; translational regulation;
D O I
10.1111/j.1601-183X.2005.00144.x
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The Fragile X Syndrome is caused by the loss of function of the FMR1 gene (Pieretti et al. 1991. Cell 66, 817-822; O'Donnell & Warren 2002. Annu Rev Neurosci 25, 315-338]. Identification of the RNA targets to which FMRP binds is a key step in understanding the function of the protein and the cellular defects caused by its absence (Darnell et al. 2004 Ment Retard Dev Disabil Res Rev 10, 49-52). Here we discuss the current understanding of FMRP as an RNA-binding protein, the different approaches that have been taken to identify FMRP RNA targets and the relevance of some of these approaches to FMRP biology. In addition, we present evidence that point mutations in the K-homology (KH)1 or KH2 domains of FMRP abrogate its polyribosome association in transfected neuroblastoma cells but that the deletion of the RGG box does not. This suggests that RNA binding by the RGG box of FMRP may mediate other aspects of cellular mRNA metabolism such as mRNA localization or that it may have a role downstream of polyribosome association. Copyright © Blackwell Munksgaard 2005.
引用
收藏
页码:341 / 349
页数:9
相关论文
共 76 条
[31]   Genome-wide analysis of RNA-protein interactions illustrates specificity of the mRNA export machinery [J].
Hieronymus, H ;
Silver, PA .
NATURE GENETICS, 2003, 33 (02) :155-161
[32]   A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins [J].
Ishizuka, A ;
Siomi, MC ;
Siomi, H .
GENES & DEVELOPMENT, 2002, 16 (19) :2497-2508
[33]   The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain [J].
Jensen, KB ;
Musunuru, K ;
Lewis, HA ;
Burley, SK ;
Darnell, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (11) :5740-5745
[34]   Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability [J].
Jensen, KB ;
Dredge, BK ;
Stefani, G ;
Zhong, R ;
Buckanovich, RJ ;
Okano, HJ ;
Yang, YYL ;
Darnell, RB .
NEURON, 2000, 25 (02) :359-371
[35]   Biochemical and genetic interaction between the fragile X mental retardation protein and the microRNA pathway [J].
Jin, P ;
Zarnescu, DC ;
Ceman, S ;
Nakamoto, M ;
Mowrey, J ;
Jongens, TA ;
Nelson, DL ;
Moses, K ;
Warren, ST .
NATURE NEUROSCIENCE, 2004, 7 (02) :113-117
[36]   IDENTIFICATION AND PURIFICATION OF A HUMAN IMMUNOGLOBULIN-ENHANCER-BINDING PROTEIN (NF-KB) THAT ACTIVATES TRANSCRIPTION FROM A HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 PROMOTER INVITRO [J].
KAWAKAMI, K ;
SCHEIDEREIT, C ;
ROEDER, RG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4700-4704
[37]   Biochemical evidence for the association of fragile X mental retardation protein with brain polyribosomal ribonucleoparticles [J].
Khandjian, EW ;
Huot, ME ;
Tremblay, S ;
Davidovic, L ;
Mazroui, R ;
Bardoni, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (36) :13357-13362
[38]   PRIMARY STRUCTURE AND BINDING-ACTIVITY OF THE HNRNP U-PROTEIN - BINDING RNA THROUGH RGG BOX [J].
KILEDJIAN, M ;
DREYFUSS, G .
EMBO JOURNAL, 1992, 11 (07) :2655-2664
[39]   The role of vasoactive compounds, growth factors and cytokines in the progression of renal disease [J].
Klahr, S ;
Morrissey, JJ .
KIDNEY INTERNATIONAL, 2000, 57 :S7-S14
[40]   Sequence-specific RNA binding by a Nova KH domain: Implications for paraneoplastic disease and the fragile X syndrome [J].
Lewis, HA ;
Musunuru, K ;
Jensen, KB ;
Edo, C ;
Chen, H ;
Darnell, RB ;
Burley, SK .
CELL, 2000, 100 (03) :323-332